Inflammatory Bowel Disease Prevalence in Patients with Hidradenitis Suppurativa Using Prospective Symptom-Based Questionnaires and Fecal Calprotectin Testing
We report an IBD prevalence of 8%, higher than previous studies. Routine IBD sign/symptom-based assessment is currently recommended. In our study, this would result in a referral rate of 44.7%. Among 88 FC tests in patients without established IBD, 1 patient was diagnosed with incident occult Crohn's disease. At a number needed to screen (NNS) of 88, routine evaluation of all patients with HS with FC may be justified especially prior to the use of interleukin (IL)-17 antagonists.
Authors
- Emily Pender (ORCID: https://orcid.org/0000-0003-1763-3173)
- Niamh Kearney (ORCID: https://orcid.org/0000-0002-6469-3462)
- Donal O’Kane (ORCID: https://orcid.org/0000-0003-0190-6114)
- Graham Turner
- Glen A. Doherty (ORCID: https://orcid.org/0000-0003-4384-5049)
- Rosalind Hughes (ORCID: https://orcid.org/0000-0001-6533-0412)
- Graham Morrison
- Collette McCourt (ORCID: https://orcid.org/0000-0002-1822-3486)
- Brian Kirby (ORCID: https://orcid.org/0000-0001-7596-892X)
- Juliette Sheridan (ORCID: https://orcid.org/0000-0002-0022-3015)
Institutions
- University College Dublin (IE)
- Belfast Health and Social Care Trust (GB)
- St. Vincent's University Hospital (IE)
Publication Details
- Journal
- Dermatology and Therapy
- Published
- 2025-05-25
- DOI
- https://doi.org/10.1007/s13555-025-01438-7
- Citations
- 2
- Primary Topic
- Hidradenitis Suppurativa and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 4.01